Benchmarking Microfluidic and Immunomagnetic Platforms for Isolating Circulating Tumor Cells in Pancreatic Cancer

Investigators highlighted the advantages of label-free microfluidic isolation and its promise for early detection, prognostic assessment, and therapeutic monitoring in pancreatic cancer.